Concepta PLC (LSE:CPT) - Share price - Overview

Stock Report

Concepta PLC CPT

Last Price
GBX12.13

Day Change
0.25|2.11%

As of 22/06/2017
11:38:36 BST | GBX
Minimum 15 Minutes Delay.

Last Close11.88p
Day Range12.00 - 12.13
Mkt Cap13.29Mil
52-Wk Range0.03 - 22.67
Yield %0.00
ISINGB00BYZ2R301
Volume17,541
P/E-3.76
P/SInfinity
P/CF-8.08

Share Price

Total Returns 22/06/2017

 Chg (%)  
More ...
Concepta PLC-20.49 
FTSE 100 TR GBP-0.45
 
Financials
201420152016
More ...
Income Statement
Turnover0.000.000.00
Operating Profit-0.52-0.16-2.79
Net Profit-0.52-0.17-2.63
Reported EPS-98.00-16.75-3.27
Balance Sheet
Current Assets0.140.073.09
Non Current Assets1.940.000.40
Total Assets2.070.543.49
Current Liabilities0.700.630.18
Total Liabilities0.700.630.18
Total Equity1.38-0.093.31
Cash Flow
Operating Cash Flow-0.29-0.33-1.60
Net Change in Cash-0.10-0.082.84
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
--------
--------

Regulatory News

DateSourceHeadline
More ...
14/06/2017|12:00RNSConcepta PLC - Result of AGM
24/05/2017|16:58RNSConcepta PLC - Notice of AGM
26/04/2017|07:00RNSConcepta PLC - Final Results

Company Profile

Concepta PLC is a women's healthcare company. The Company develops proprietary platform and suite of products at the personalised mobile health market, on women's fertility and specifically unexplained infertility.

Sector

Medical Devices

Market Position

1460 of 1843 Companies

Index

FTSE AIM All Share

Outlook

(13/06/2017) The company has received its first sales order for RMB 1.95m for its myLotus fertility products from its partner in China, HuanZhong Biotech Co.Ltd. This sales order represents the first purchase for the company's myLotus products and will see HZ Biotech distribute myLotus products in China to help achieve market penetration for the initial launch of the product in the country. The board anticipates that further sales orders will be made by HZ Biotech in line with its partner agreement and will update the market on these developments accordingly.

Next Event 18/08/2017

Next interim announcement
Ratios
CompSecMkt
More ...
PER (E)0.0020.8116.88
Div Yld (E)0.001.574.13
PEG (E)0.00-0.331.19
ROCE-89.0019.16209.80
Op Mrgn0.004.06-99.88
EPS Grwth0.00113.2933.48
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Adam Reynolds
Chief Executive OfficerErik Henau
Finance Director & Company SecretaryMrs. Barbara Spurrier
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.